Posts

Alopecia Market

Alopecia Market

/in /by

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Market Synopsis

The global alopecia market size was valued at USD 2,650.8 Million in 2019 and is forecasted to reach USD 5,250.8 Million by 2027 at a CAGR of 8.9%. The alopecia market is projected to experience rapid growth attributed to the prevalence of various disease types comprising alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, and cicatricle alopecia. Factors such as increasing incidence of chronic diseases, rising cases of Polycystic Ovary Syndrome (PCOS), rise in the level of disposable income, and advancements in medical technology for delivering enhanced treatment.

Diseases such as thyroid disorders, cancer, lupus, muscular dystrophy, heavy metal poisoning, pituitary gland disease, sarcoidosis, syphilis in last-stage, and continuing chronic diseases may lead to alopecia. It has been found that about 65.0% of people receiving chemotherapy are likely to suffer from chemotherapy-induced hair loss. In comparison, the deployment of cancer treatment with molecularly targeted agents has been linked with hair loss rates up to a maximum of 60.0%.

Additionally, advancements in technology and usage of emerging therapeutics such as stem cells, cellular pathways, growth factors, and robotic hair transplant, for alopecia, provide ample opportunities to boost the market growth.

However, a low level of awareness about the condition may hamper the market’s growth in the forecast period.Type Insights

By type, alopecia areata accounted for the largest market share of over 31.0% of the alopecia market in 2019

Alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence. In the US, it affects approximately 6.8 million individuals. In a large number of cases, this condition causes hairs to fall-out in various amounts ranging from small patches to severe hair loss. Occasionally, it may result in total hair loss on the scalp and the whole body in extreme conditions. The disease affects individuals regardless of their gender and age.

The disease’s likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population.

Application Insights

By application, men accounted for the largest market share 65.0% of the alopecia market in 2019

Alopecia/hair-loss in men caused several factors, including smoking, consumption of alcoholic beverages, stress, drug abuse, and genetics, among other factors. Male pattern baldness or androgenic alopecia, a hereditary cause of hair loss, may be triggered at any point in a man’s life, including adolescence.

As per a study conducted by the US National Library of Medicine (NLM), over 50.0% of the global male population beyond the age of 50 will experience male pattern baldness to a certain extent.

End-Users Insights

By end-users, dermatology clinics is likely to grow at the fastest rate of 9.5% in the forecast period

Dermatology clinics expert medical professionals trained for diagnosing conditions including skin (scalp) and hair. Dermatologists help find the root cause of hair problems and successfully cure hair-loss in several cases. The high market share of dermatology clinics is due to the rising number of surgeries associated with hair transplantation and restoration and the extensive usage of prescription drugs.

Dermatology clinics possess the expertise to prevent thinning of hairs and boost hair growth. In the US, the FDA has sanctioned minoxidil for the treatment of hair loss and is the only approved hair re-growth product. A dermatologist can incorporate minoxidil with other treatment methods to cure hair loss.

Regional Insights

By region, North America accounted for the largest market share of over 36.0% of the alopecia market in 2019

The North American region’s market dominance is due to the high alopecia incidence, advanced healthcare infrastructure, high per-capita income, and accessibility to innovative treatment options for hair loss. Increased investment in R&D and a rising number of patent approvals in the region are also causatives of market growth.

The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period attributed to increasing incidence of chronic disorders, growing awareness among the population, especially in people of the young generation, and a rise in the level of disposable income.

Major Companies and Market Share Analysis

The leading players in the alopecia market are equipped with enhanced production facilities and are involved in various R&D activities. A few leading players in the alopecia market include:

  • Johnson & Johnson Services Inc.
  • Cirrus Hair Centers
  • Cipla Inc.
  • Follica Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Convert Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Aclaris Therapeutics Inc.
  • HCell Inc.

In January 2020, Revian made an announcement about the receiving of a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues such as including hair.

Scope Of Research

PARAMETERS
DETAILS

The market size value in 2019
USD 2,650.8 million

CAGR (2020 – 2027)
8.9%

The revenue forecast in 2027
USD 5,250.8 million

Base year for estimation
2020

Historical data
2017-2019

Forecast period
2021-2028

Quantitative units
Revenue in USD Billion, and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, application, end-users, Region

Regional scope

North America; Europe; Asia Pacific; Central & South America; MEA

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey

Key companies profiled

Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc.

Customization scope

10 hrs of free customization and expert consultation

Segments Covered in the report

 

This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027. The scope of the report can be defined as:

For the purpose of this report, Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027) 
    • Alopecia Areata
    • Androgenetic Alopecia
    • Alopecia Totalis
    • Traction Alopecia
    • Cicatricle Alopecia
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027) 
    • Male
    • Female
  • End-Users Outlook (Revenue, USD Billion; 2017-2027) 
    • Dermatology Clinics
    • Homecare Settings
    • Others
  • Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) 
    • Prescription
    • OTC (Over-the-Counter)
  • Regional Outlook (Revenue, USD Billion; 2017-2027) 
    • North America

      1. U.S.
      2. Canada
      3. Mexico
    • Europe

      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific

      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America

      1. Brazil
      2. Rest of LATAM
    • MEA

      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Source

Recent Posts

Alopecia Market

Alopecia Market

/in /by

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Market Synopsis

The global alopecia market size was valued at USD 2,650.8 Million in 2019 and is forecasted to reach USD 5,250.8 Million by 2027 at a CAGR of 8.9%. The alopecia market is projected to experience rapid growth attributed to the prevalence of various disease types comprising alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, and cicatricle alopecia. Factors such as increasing incidence of chronic diseases, rising cases of Polycystic Ovary Syndrome (PCOS), rise in the level of disposable income, and advancements in medical technology for delivering enhanced treatment.

Diseases such as thyroid disorders, cancer, lupus, muscular dystrophy, heavy metal poisoning, pituitary gland disease, sarcoidosis, syphilis in last-stage, and continuing chronic diseases may lead to alopecia. It has been found that about 65.0% of people receiving chemotherapy are likely to suffer from chemotherapy-induced hair loss. In comparison, the deployment of cancer treatment with molecularly targeted agents has been linked with hair loss rates up to a maximum of 60.0%.

Additionally, advancements in technology and usage of emerging therapeutics such as stem cells, cellular pathways, growth factors, and robotic hair transplant, for alopecia, provide ample opportunities to boost the market growth.

However, a low level of awareness about the condition may hamper the market’s growth in the forecast period.Type Insights

By type, alopecia areata accounted for the largest market share of over 31.0% of the alopecia market in 2019

Alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence. In the US, it affects approximately 6.8 million individuals. In a large number of cases, this condition causes hairs to fall-out in various amounts ranging from small patches to severe hair loss. Occasionally, it may result in total hair loss on the scalp and the whole body in extreme conditions. The disease affects individuals regardless of their gender and age.

The disease’s likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population.

Application Insights

By application, men accounted for the largest market share 65.0% of the alopecia market in 2019

Alopecia/hair-loss in men caused several factors, including smoking, consumption of alcoholic beverages, stress, drug abuse, and genetics, among other factors. Male pattern baldness or androgenic alopecia, a hereditary cause of hair loss, may be triggered at any point in a man’s life, including adolescence.

As per a study conducted by the US National Library of Medicine (NLM), over 50.0% of the global male population beyond the age of 50 will experience male pattern baldness to a certain extent.

End-Users Insights

By end-users, dermatology clinics is likely to grow at the fastest rate of 9.5% in the forecast period

Dermatology clinics expert medical professionals trained for diagnosing conditions including skin (scalp) and hair. Dermatologists help find the root cause of hair problems and successfully cure hair-loss in several cases. The high market share of dermatology clinics is due to the rising number of surgeries associated with hair transplantation and restoration and the extensive usage of prescription drugs.

Dermatology clinics possess the expertise to prevent thinning of hairs and boost hair growth. In the US, the FDA has sanctioned minoxidil for the treatment of hair loss and is the only approved hair re-growth product. A dermatologist can incorporate minoxidil with other treatment methods to cure hair loss.

Regional Insights

By region, North America accounted for the largest market share of over 36.0% of the alopecia market in 2019

The North American region’s market dominance is due to the high alopecia incidence, advanced healthcare infrastructure, high per-capita income, and accessibility to innovative treatment options for hair loss. Increased investment in R&D and a rising number of patent approvals in the region are also causatives of market growth.

The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period attributed to increasing incidence of chronic disorders, growing awareness among the population, especially in people of the young generation, and a rise in the level of disposable income.

Major Companies and Market Share Analysis

The leading players in the alopecia market are equipped with enhanced production facilities and are involved in various R&D activities. A few leading players in the alopecia market include:

  • Johnson & Johnson Services Inc.
  • Cirrus Hair Centers
  • Cipla Inc.
  • Follica Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Convert Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Aclaris Therapeutics Inc.
  • HCell Inc.

In January 2020, Revian made an announcement about the receiving of a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues such as including hair.

Scope Of Research

PARAMETERS
DETAILS

The market size value in 2019
USD 2,650.8 million

CAGR (2020 – 2027)
8.9%

The revenue forecast in 2027
USD 5,250.8 million

Base year for estimation
2020

Historical data
2017-2019

Forecast period
2021-2028

Quantitative units
Revenue in USD Billion, and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, application, end-users, Region

Regional scope

North America; Europe; Asia Pacific; Central & South America; MEA

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey

Key companies profiled

Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc.

Customization scope

10 hrs of free customization and expert consultation

Segments Covered in the report

 

This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027. The scope of the report can be defined as:

For the purpose of this report, Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027) 
    • Alopecia Areata
    • Androgenetic Alopecia
    • Alopecia Totalis
    • Traction Alopecia
    • Cicatricle Alopecia
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027) 
    • Male
    • Female
  • End-Users Outlook (Revenue, USD Billion; 2017-2027) 
    • Dermatology Clinics
    • Homecare Settings
    • Others
  • Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) 
    • Prescription
    • OTC (Over-the-Counter)
  • Regional Outlook (Revenue, USD Billion; 2017-2027) 
    • North America

      1. U.S.
      2. Canada
      3. Mexico
    • Europe

      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific

      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America

      1. Brazil
      2. Rest of LATAM
    • MEA

      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Source

Recent Posts

Alopecia Treatment Market

Alopecia Market

/in /by

Alopecia Market

The Alopecia Market is expected to reach USD 12.99 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the rising predominance of chronic disorders such as hyperthyroidism, hypothyroidism, acute stress disorder, lupus, and hypopituitarism.

Moreover, increasing incidence of Hodgkin’s disease, Hashimoto’s disease, Addison’s disease, and celiac disease along with factors such as access to treatment quickly are expected to drive the market growth. However, the high cost of treatment and adverse side effects is expected to restrain the growth.

Also, changing lifestyle such as consumption of tobacco, an increase in the use of alcohol, and other associated products, growing stress levels, and the expanding population are expected to spur the market. Increasing disposable incomes coupled with expanding emphasis on aesthetic appearance are also likely to add to the demand for alopecia treatment worldwide.

Hair loss, also acknowledged as alopecia or baldness refers to a loss of hair from part of the head.

The typical pattern of hair loss can vary from a small area to the entire body. Scarring or inflammation is not present. Hair loss in some people may cause psychological distress. General types include female-pattern hair loss, male-pattern hair loss, alopecia areata, and a thinning of hair also known as telogen effluvium.

The cause of male-pattern hair loss is a combination of male hormones and genetics, the purpose of female pattern hair loss is not clear, the use of alopecia areata is auto-immune, and the cause of telogen effluvium is mostly a psychological or physically stressful event.

The rising number of the introduction of new drugs, consumer disposable incomes, and the complementary initiatives taken by the relevant organizations namely, AHLA and NAAF, are the crucial factors for the North America region to account for the largest market share of 22.30% in 2018.

Key Coverage of the Report

•Region and country-wise statistics of Alopecia Market from the period 2016-2026. While 2016-2017 has been utilized as historical data, 2018 is considered the base year. 2019-2026 have been derived as forecasts.
•Estimation of the market size along with historic and forecasted trend analysis.
•Various Cure Types of Alopecia Market technique have been analyzed. Statistical analysis has been conducted on obtaining the individual share of these segments.
•Regional up-coming Alopecia Market outlook.
•Regional prevalence of the market has been mapped.
•Demand and Supply GAP Analysis
•Regional Competitors Pricing Strategy
•Market share analysis of the top industry players
•Strategic recommendations for the new entrants
•Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
•Strategic recommendations in key business segments based on the market estimations
•Competitive landscaping mapping the key common trends
•Company profiling with detailed strategies, financials, and recent developments.

Salient Trends of the Alopecia Market

•The market is projected to grow at a CAGR of 1% in terms of value and reach USD 12.99 billion in 2026.
•Based on disease type, the alopecia market is classified into androgenetic alopecia, alopecia areata (AA), and others. Androgenetic type led this market in 2018 with the largest revenue of USD 3.65 billion in 2018 and is expected to grow at a favourable rate over the forecast period.
•Alopecia areata is an autoimmune skin disease identified by the hair loss on the scalp, face, and other areas of the body. Alopecia areata is segmented into totalis, patchy, and universalis further.
•The rising predominance of alopecia areata owing to autoimmune diseases such as diabetes, hyperthyroidism, and Down’s syndrome is expected to drive demand over the forecast period.
•Increasing predominance coupled with rising awareness regarding aesthetic appeal and physical appearance is also assumed to drive market growth in the next few years.
•Alopecia areata is expected to be the fastest-growing market with a CAGR of 5.2% during the forecast period.
•Steroid injections may treat alopecia areata in the affected area, but these need to be continuously repeated to be effective. Hair loss is a common problem. The pattern of hair loss by age 50 affects about half of males and a quarter of females. About 1-2% of people develop alopecia areata at some point in time.
•Male-Pattern Hair Loss (MPHL) or Androgenetic alopecia is associated with various medical conditions such as diabetes, coronary heart disease, obesity, prostate cancer, hypertension, and Polycystic Ovary Syndrome (PCOS).
•Also, the availability of treatments such as oral treatments, licensed topical treatments involving the use of finasteride and minoxidil; and surgical procedures such as hair replacement and transplantation are expected to drive the market.
•Laser treatments are also becoming common for non-invasive approach. Such non-invasive treatment approaches are also likely to drive the androgenetic segment.
•The global Alopecia Market is growing at a rapid speed owing to the increase in stress and changed lifestyle.
•The market can be classified into home care settings and dermatology clinics, based on application. Dermatology clinics account for the largest market share of 54.24% in 2018 and are anticipated to grow at a fruitful rate over the forecast period.
•Dermatology clinics coupled with innovative technologies and prescription hair care products help many affected individuals fight their condition.
•Consultation with dermatologists is regarded as the best option for the treatment, as they prescribe suitable medication or therapy for effective results. These factors are responsible for the high need for dermatology clinics for hair loss treatment.
•On the other hand, treatment in-home care settings is expected to grow at a rate of 5.1% during the forecast period.
•Prescription medicine segment is anticipated to grow owing to increasing disposable income and quickly changing lifestyle. Finasteride and Corticosteroids are some of the majorly prescribed medications.
•Based on the sales distribution, the market is segmented into prescription-based medications or treatment devices and Over the Counter (OTC).
•Sale of prescription products account for the larger market share of 68.85% in 2018 and is estimated to reach USD 5.95 billion by 2026.
•The OTC segment is expected to grow at a rate of 5.1% during the forecast period.
•Increasing R&D efforts to improve treatments, FDA approvals obtained for certain products and strategic initiatives taken by the key players, are the primary competitive strategies paving the way for market expansion.
•In April 2016, Johnson & Johnson announced the launch of a new global healthcare initiative to implement healthcare solutions, in Africa.
•The developing prosperity of countries such as Indonesia, Taiwan, China, and India is inviting new international ventures in these countries thereby leading to the growth of various industries in the APAC region.

Companies considered and profiled in this market study

Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc.,  Cirrus Hair Centers, Lexington International LLC,  Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

Market-O-Nomics

•Rising demand for low-cost treatment, growing awareness regarding adverse effects of prescribed drugs, and the increasing availability of options are spurring the need for OTC products.
•Moreover, a surge in the number of FDA-approved OTC products for hair loss treatments is additionally expanding their demand. Some of the FDA-approved OTC products for hair loss treatment are Oscar Blandi hair lift instant thickening and strengthening serum and Keranique hair regrowth system.
•In 2018, the dominant gender segment for the alopecia market is women that accounts for the larger market share of 56.48%. The growing awareness amongst women about alopecia and the importance laid upon appearance by them are the key drivers of this segment.
•Due to the predominance of a vast number of new entrants established manufacturers, and suppliers in the market, the industry is extremely competitive.
•Asia Pacific is forecasted to witness the fastest CAGR of 5.4% during the forecast period. A vast population suffering from alopecia and growing awareness about the available therapeutic options are the key growth drivers.
•Economic development coupled with continually increasing per capita healthcare investment in emerging countries such as India, China, and Singapore is expected to create high growth opportunities.
•Innovations and technological trends in treatment, evolving healthcare expenditures, and increased healthcare facilities are expected to drive the growth further.

Segments Covered in the report:

This report forecasts revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2026.

For the purpose of this study, Reports and Data have segmented the global Alopecia Market on the basis of Disease, Gender, application, Sales distribution and region:

Disease Outlook (Revenue, USD Million; 2016-2026)

•Alopecia Areata
•Androgenetic Alopecia
•Others

Sales distribution Outlook (Revenue, USD Million; 2016-2026)

•Prescriptions
•OTC

Application Outlook (Revenue, USD Million; 2016-2026)

•Homecare Settings
•Dermatology Clinics

Gender Outlook (Revenue, USD Million; 2016-2026)

•Female
•Male

Regional Outlook (Revenue, USD Million; 2016-2026)

•North America

◦U.S.

•Europe

◦Germany
◦UK

•Asia Pacific

◦China
◦India
◦Southeast Asia

•Latin America

◦Brazil

•Middle East & Africa

Alopecia Market

Source

Recent Posts

Alopecia Treatment Market

Alopecia Treatment Market

/in /by

Alopecia Treatment Market Foreseen To Encounter Sluggish Development Amid 2023

Dr. Reddy’s Laboratories, Nanogen, Merck & Co, Vitabiotics, Viviscal, Kirkland Signature, Cipla, Phyto – Alès Groupe and Johnson and Johnson.

Alopecia Treatment Market

A Crystal Market Research Recently released the Alopecia Treatment Market dynamics, forces, companies, and trends have been determined after conducting a detailed study of the industry for this newly released research report now available with

Market Study Report.

Market Outlook and Trend Analysis

The Alopecia Treatment Market has encountered significant development in recent years and is anticipated to grow tremendously over

the forecast period. Alopecia also recognized as hair-loss or baldness is a medicinal condition that alludes to the loss of hairs from the head or any part of the body. The condition can happen in both male and female and at any age.

There are five main kinds of alopecia to be specific; androgenic alopecia, cicatricial alopecia, androgenic alopecia, alopecia totalis, and traction alopecia. Alopecia areata is a typical autoimmune disorder in which the safe arrangement of body assaults the sound hair follicle prompting hair fall.

Development of the alopecia treatment market is fundamentally determined by expanding interest in hair loss treatment drugs with improved viability and insignificant reactions. For instance, as of late cytokine therapy too regenerative cell treatment is picking up demand for treatment of different sorts of alopecia. Treatment with cytokine treatment has expanded capacity in hair regrowth bringing about hair follicle cells to get differenced and multiplied while controlling hair growth cycle.

Competitive Outlook

The leading players in the market are Ranbaxy Laboratories, Dr. Reddy’s Laboratories, Nanogen, Merck & Co, Vitabiotics, Viviscal, Kirkland Signature, Cipla, Phyto – Alès Groupe and Johnson and Johnson. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Regional Insights

North America, trailed by Europe, is foreseen to overwhelm the alopecia treatment market all through the conjecture time frame. The Asia Pacific is anticipated to witness the speediest development attributable to the upheaval of the middle-aged populace in the area. Likewise, the district is observing sound development as far as GDP, which is anticipated to move development at solid digits. The Middle East and Africa and Latin America are foreseen to encounter sluggish development amid the conjecture time frame.

Market Segmentation-

Alopecia Treatment, By Disease Type

Androgenic Alopecia

o Cicatricial Alopecia
o Alopecia Areata
o Traction Alopecia
o Alopecia Totalis

Alopecia Treatment, By Treatment Type

Topical Drugs

o Injectable
o Low-Level Laser Therapy
o Oral Drugs
o Hair Transplant Services
Alopecia Treatment, By End User
Homecare Settings
o Dermatology Clinics
o Others

By Region-

The Middle East And Africa (Saudi Arabia, UAE, Egypt, Nigeria, And South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest Of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
Rest Of The World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing the forecast. Our research process commences by analyzing the problem which enables us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to the changing nature of products and markets while retaining the core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Major Table of Contents:

Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (the United States, Canada, and Mexico)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.5. The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA
5. Alopecia Treatment Market, By Disease Type
5.1. Introduction
5.2. Global Alopecia Treatment Revenue and Market Share By Disease Type (2014-2018)
5.2.1. Global Alopecia Treatment Revenue and Revenue Share By Disease Type (2014-2018)
5.3. Androgenic Alopecia
5.3.1. Global Androgenic Alopecia Revenue and Growth Rate (2014-2018)
5.4. Cicatricial Alopecia
5.4.1. Global Cicatricial Alopecia Revenue and Growth Rate (2014-2018)
5.5. Alopecia Areata
5.5.1. Global Alopecia Areata Revenue and Growth Rate (2014-2018)
5.6. Traction Alopecia
5.6.1. Global Traction Alopecia Revenue and Growth Rate (2014-2018)
5.7. Alopecia Totalis
5.7.1. Global Alopecia Totalis Revenue and Growth Rate (2014-2018)
6. Alopecia Treatment Market, By Treatment Type
7. Alopecia Treatment Market, By End User
8. Alopecia Treatment Market, By Region
……CONTINUED FOR TOC
To Know About Full TOC of This Report Is Available here, Please Click on
www.crystalmarketresearch.com/report/alopecia-treatment-m…

About Crystal Market Research:

Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.

Alopecia Treatment Market Foreseen To Encounter Sluggish Development Amid 2023

Source

Global Alopecia Drugs Market Insights Report

Alopecia Market Pipeline H1 Review

/in /by

Alopecia Market Pipeline H1 Review Products in Clinical Stage, Methodology, Therapeutic Landscape and R&D Progress

Alopecia Market – Pipeline Review H1 2018, provides detail overview of Alopecia development scenario.

This report delivers top-line data relating to the Alopecia Market pipeline landscape and also includes important players/vendors, Drugs Profile, Therapeutics Development, Molecule Type, Mechanism of Action.

Alopecia Market report additionally, provides an overview of key players involved in therapeutic development for Alopecia Market and features dormant and discontinued projects. The report also covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Ask for PDF Sample of this Alopecia Market Report https://www.absolutereports.com/enquiry/request-sample/11716319

Some of The Key Players of Alopecia Market Pipeline Therapeutics Include: Aclaris Therapeutics Inc, Allergan Plc, Almirall SA, AndroScience Corp, Berg LLC, BiologicsMD Inc, BirchBioMed Inc, Brickell Biotech Inc, Bristol-Myers Squibb Co, Cassiopea SpA and More

Alopecia Market Report Highlights:

Alopecia Market Pipeline report guide covers comprehensive information on the therapeutics under development for Alopecia Market complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Alopecia Market pipeline helps in identifying and tracking emerging players in the market and their portfolios enhance decision-making capabilities and help to create effective counter-strategies to gain competitive advantage.

The Scope of Alopecia Market:

Alopecia Market pipeline support provides a snapshot of the global therapeutic landscape.
The pipeline guide reviews key companies involved in Alopecia therapeutics and enlists all their major and minor projects.

Alopecia pipeline help to covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Alopecia Market pipeline adviser to evaluates therapeutics based on a mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The guide is built using data and information sourced from company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real-time basis.

Reasons to buy of Alopecia Market:

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with the potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Alopecia Market
Classify potential new clients or partners in the target demographic.

Price of Report: $ 2000 (Single User License)

Purchase Report at https://www.absolutereports.com/purchase/11716319

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Alopecia Market pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from a pipeline.

Alopecia Market Pipeline H1 Review

Source

Global Alopecia Drugs Market Insights Report

Global Alopecia Market 2017 Sales

/in /by

Global Alopecia Market 2017 Sales, Trends, Analysis, Growth & Forecast to 2027

The Advancement of “Alopecia Market report with Epidemiology Forecast to 2027”, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Alopecia market analyzes the current and future prospects of the Alopecia market worldwide. The stakeholders of this report include companies engaged in production and marketing of Alopecia systems across the globe.

The pharmaceuticals market is in its growth stage and successfully endeavour the dimensions of the fast growing market by providing cutting-edge market and Epidemiology information.

 

Alopecia Market Segment by Regions: – United States (USA, Canada and Mexico), EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Major Key Players of Alopecia Market: Company 1, Company 2, Company 3, Company 4 and more.

Key Competency of Alopecia Market Report as: –
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Alopecia

Enquire about Alopecia Market Report at: –

https://www.marketreportsworld.com/enquiry/pre-order-enquiry/10918025

Alopecia Market Epidemiology Algorithm and Regional analysis: –

The epidemiology section covers the historical, current as well as forecasted epidemiology for Alopecia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports.

The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Alopecia outlook. It also includes the explanation of changing trends of epidemiology outlining the Alopecia scenario.

What Information does this report contain?

What was the historic market data from, what is the industry growth forecast from to 2027?

A detailed analysis of regulatory trends, growth, industry pitfalls, challenges and opportunities for participants?

Which are the leading market products, applications & regions and how will they perform by 2027?

What is the technology & innovation trends, how will they evolve by 2027?

Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

Alopecia Market Report Assessment:

Patient Segmentation in Alopecia
Alopecia Risk & Burden and Factors driving growth in a specific Alopecia patient population
Purchase Alopecia Market Report at (Single User License) at:

Key Topics Covered in Alopecia research report:

Research Methodology
Executive Summary
Strategic Recommendations
Alopecia Industry Outlook, Year 2016-2027
Alopecia Market Environment
Alopecia Outlook
Alopecia Market: Growth and Forecast
Alopecia Market – Epidemiology and Patient Population
United States Alopecia Market: Prevalent/Incident Cases, Sub-Type Specific cases, Sex- Specific Cases, Diagnosed Cases
EU5 Alopecia Market: Prevalent/Incident Cases, Sub- Type Specific cases, Sex- Specific Cases, Diagnosed Cases
Japan Alopecia Market: Prevalent/Incident Cases, Sub-Type Specific cases, Sex- Specific Cases, Diagnosed Cases
Market Dynamics and Sources

Top 4 Reasons of Potential Growth of Alopecia Market Report as: –

The report covers detailed overview of Alopecia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

The Alopecia Report assesses the disease risk and burden and highlights the unmet needs

It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Source

Improved Minoxidil Formulation Safe, Effective for Androgenetic Alopecia

Global Alopecia Market forecast 2018

Global Alopecia Market forecast 2018

/in /by

Global Alopecia Market forecast 2018: Company, Region, Type and Applications

Alopecia Market 2018 Report Point on in-depth Alopecia market analysis with future prospects of Alopecia market. Alopecia Market research report includes diverse topics like total market size, key market drivers, challenges, growth opportunities, technological changes, key players etc. of Alopecia market to calculate the market size.

Alopecia Market report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Alopecia development.

 

Key features of this report:-

Alopecia market dynamics, Latest innovations and key events in the industry, Analysis of business strategies of the top players, Alopecia market estimates and forecasts.

Top manufacturers covered in Alopecia Market reports are: – Company 1, Company 2, Company 3, Company 4, Company 5 and many more…

Key Assistance of Alopecia Market Report as:-

Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications for the market.

Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.

Analysis of the current and future market competition in the Alopecia market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Pipeline therapeutics assessment divided into:-

Development stage
Therapy type
Route of administration
Molecule type
Developmental Stages of Alopecia Market Pipeline Products are:

Clinical
Non-clinical
Inactive: Discontinued and/or Dormant
Find more information about Alopecia Market report?

There are 08 Chapters to thoroughly display the Alopecia market:

Chapter 1: Alopecia Market Overview, Pipeline Therapeutics, Product Overview, Market Segmentation, Limitations, Opportunities and Industry News and Policies by Regions

Chapter 2: to describe the Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis and Major Downstream Buyers of Alopecia Analysis

Chapter 3: Comparative Analysis, Value Analysis, Production, Growth Rate and Price Analysis by Type of Alopecia

Chapter 4: Consumption and Market Share by Application and Downstream Market Overview of Alopecia

Chapter 5: Research and Development Analysis

Chapter 6: Production, Consumption, Export and Import by Regions

Chapter 7: Therapeutic Assessment Alopecia Market Status and SWOT Analysis by Regions

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles and Market Positioning of Alopecia, Product Development Activities.

Purchase Alopecia market Report at:-

https://www.marketreportsworld.com/purchase/10919158

Alopecia Market Pipeline therapeutics development coverage provides descriptive product profiles including drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patient details.

Source

alopecia report

Alopecia Market Overview

/in /by

Alopecia Market Overview with forecasted data and Key Findings and manufactures analysis

“Alopecia -Epidemiology Forecast provides an overview of the epidemiology trends of Alopecia  in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).

It includes 10 years epidemiology historical and forecasted data of Insulin Resistance.

The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.

Sample Pdf of Report at:- https://www.marketreportsworld.com/enquiry/request-sample/10754377

Key Coverage and Benefits of Alopecia  Market Report

• The Report includes the prevalent population and how will it change over the next eight years.
• Coverage of key Alopecia  sub-populations and its prevalent or incident cases
• Prevalent or incident cases segmented by age and sex.
• The key differences in epidemiology patterns across the seven market segments.

Major Points to buy Alopecia  Market Overview Report

Developing business strategies by understanding the trends shaping and driving the global Alopecia market.
• Identifying prevalent patient populations as well as risk factors in the global Alopecia market will help to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Alopecia  therapeutics in each of the markets covered.

Important Points Covered in TOC of Alopecia – Epidemiology Forecast

Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
• Key Findings
4. Alopecia Overview
• Alopecia  Definition
• Pathophysiology
• Symptoms
• Etiology
5. Risk Factors Associated with Alopecia
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
• Key Findings
• Key Sources used and Forecast Methodology
• Prevalent Cases and Incident Cases-2015-2025
• Prevalent & Incident Cases by Category-2015-2025
• Age-Specific Prevalent/ Incident Cases of Alopecia
• Sex-Specific Prevalent/Incident Cases of Alopecia
• Disease Type Specific Prevalent/Incident Cases of Alopecia
8.Prevalent & Incident Cases by 7 MM-2015-2025
• Alopecia  Epidemiology of United States-2025
• Alopecia  Epidemiology of United Kingdom-2025
• Alopecia  Epidemiology of Germany-2025
• Alopecia  Epidemiology of France-2025
• Alopecia  Epidemiology of Spain-2025
• Alopecia  Epidemiology of Italy-2025
• Alopecia  Epidemiology of Japan-2025

Source